Arix Bioscience plc 4
4 · Harpoon Therapeutics, Inc. · Filed Dec 10, 2019
Insider Transaction Report
Form 4
Arix Bioscience plc
10% Owner
Transactions
- Sale
Common stock
2019-12-06$19.15/sh−47,752$914,222→ 2,844,367 total(indirect: See Footnote) - Sale
Common stock
2019-12-09$18.30/sh−26,438$483,781→ 2,817,929 total(indirect: See Footnote) - Sale
Common stock
2019-12-09$18.12/sh−77,316$1,400,664→ 2,740,613 total(indirect: See Footnote) - Sale
Common stock
2019-12-10$16.91/sh−131,696$2,227,019→ 2,608,917 total(indirect: See Footnote)
Footnotes (1)
- [F1]These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.